Kestrel

Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services

University Hospitals of Derby and Burton NHS Foundation Trust · published Wed 7 Oct 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by Rosemont Pharmaceuticals Ltd and Prulab Pharma Ltd and Vertical Pharma Resources Ltd and 2 more in Oct 2026, for £1m.

What you're up against

  • The last two awards went to different firms: this buyer has changed supplier before.
  • 13 different firms won this buyer's 3 awards for this kind of work since 2025.
  • It last went for £1m in 2026.
  • The last award named 5 suppliers: it may be a framework, where many firms are chosen.

From University Hospitals of Derby and Burton NHS Foundation Trust's earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The notice doesn't say where the documents are, but University Hospitals of Derby and Burton NHS Foundation Trust's other tenders use health-family.force.com. Register there (it's free) and look for this tender, or email the buyer's contact on the notice.

The notice as published

The East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-provider Framework Agreement for its members the Dose Banded Products & Patient Specific Chemotherapy Services as defined in this specification. This procurement exercise is being carried out as an Open Procedure under the PA23 Regulations. The Framework will run for an initial 2 Year period with an option to extend for a further 2 Years. (2 + 2 - maximum duration 4 Years) This a new PME notice published due to changes in the Procurement Timetable. The previous notice was published on 12th May 2025 under 2025/S 000-020394.